title: Alemtuzumab for giant cell hepatitis with autoimmune hemolytic anemia.
authors.affiliation: Department of Pediatrics, University of Milano-Bicocca, Italy. attilio.rovelli@pediatriamonza.it
authors.forename: Attilio
authors.initials: A
authors.lastname: Rovelli
authors.forename: Paola
authors.initials: P
authors.lastname: Corti
authors.forename: Chiara
authors.initials: C
authors.lastname: Beretta
authors.forename: Giorgio
authors.initials: G
authors.lastname: Bovo
authors.forename: Valentino
authors.initials: V
authors.lastname: Conter
authors.forename: Giorgina
authors.initials: G
authors.lastname: Mieli-Vergani
mesh_terms: D000074323:Alemtuzumab; D000744:Anemia, Hemolytic, Autoimmune / Q000150:complications* / Q000175:diagnosis; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived; D000912:Antibodies, Neoplasm / Q000009:adverse effects / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001379:Azathioprine / Q000008:administration & dosage; D001706:Biopsy; D002446:Celiac Disease / Q000150:complications / Q000175:diagnosis / Q000178:diet therapy; D002675:Child, Preschool; D003298:Coombs Test; D016572:Cyclosporine / Q000008:administration & dosage; D003937:Diagnosis, Differential; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000008:administration & dosage; D006505:Hepatitis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007223:Infant; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008111:Liver Function Tests; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives; D011241:Prednisone / Q000008:administration & dosage; D035583:Rare Diseases; D012074:Remission Induction / Q000379:methods; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived; D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; D005938:Glucocorticoids; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D000074323:Alemtuzumab; D000069283:Rituximab; D016572:Cyclosporine; D009173:Mycophenolic Acid; D001379:Azathioprine; D011241:Prednisone; D008775:Methylprednisolone